Phibro Animal Health Corporation Class A earnings per share and revenue
On Nov 05, 2025, PAHC reported earnings of 0.73 USD per share (EPS) for Q1 26, beating the estimate of 0.63 USD, resulting in a 14.96% surprise. Revenue reached 363.89 million, compared to an expected 353.90 million, with a 2.82% difference. The market reacted with a +4.59% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 0.68 USD, with revenue projected to reach 362.75 million USD, implying an decrease of -6.85% EPS, and decrease of -0.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Phibro Animal Health Corporation Class A's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Phibro Animal Health Corporation Class A reported EPS of $0.73, beating estimates by 14.96%, and revenue of $363.89M, 2.82% above expectations.
How did the market react to Phibro Animal Health Corporation Class A's Q1 2026 earnings?
The stock price moved up 4.59%, changed from $41.15 before the earnings release to $43.04 the day after.
When is Phibro Animal Health Corporation Class A expected to report next?
The next earning report is scheduled for Feb 04, 2026.
What are the forecasts for Phibro Animal Health Corporation Class A's next earnings report?
Based on 6
analysts, Phibro Animal Health Corporation Class A is expected to report EPS of $0.68 and revenue of $362.75M for Q2 2026.